Sự khác biệt về chủng tộc trong điều trị hạ huyết áp: Bằng chứng và những hệ lụy

Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effect of treatment on morbidity in hypertension: Results in patients with diastolic blood pressures averaging 115 through 129 mmHg.JAMA 1967;1028–1034. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: Risk factor changes and mortality results.JAMA 1982;248:1465–1477. Weinberger MH. Diuretics and their side effects. Dilemma in the treatment of hypertension.Hypertension 1988; 11(Suppl 2):II16-II20. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The 1988 Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure.Arch Intern Med 1988;148:1023–1038. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. I. Results of short-term titration with emphasis on racial differences in response.JAMA 1982;248:1996–2003. Richardson DW, Freund J, Gear AS, Mauck HP Jr, Preston IW. Effect of propranolol on elevated arterial pressure.Circulation 1968;37:534–542. Holland OB, Gomez-Sanchez CE, Kuhnert L, Poindexter C, Pak CYC. Antihypertensive comparison of furosemide with hydrochlorothiazide for black patients.Arch Intern Med 1979;139:1015–1021. Moser M, Lunn J. Responses to captopril and hydrochlorothiazide in black patients with hypertension.Clin Pharmacol Ther 1982;32:307–312. Luft FC, Grim CE, Higgins JT Jr, Weinberger MH. Differences in response to sodium administration in normotensive white and black subjects.J Lab Clin Med 1977;90:555–561. Luft FC, Grim CE, Fineberg MS, Weinberger MH. Effects of volume expansion and contraction in normotensive whites, blacks and subjects of different ages.Circulation 1979;59:643–650. Luft FC, Fineberg MS, Miller JZ, Rankin LI, Grim CE, Weinberger MH. The effects of age, race and heredity on creatinine clearance in normal man.Am J Med Sci 1980;279:15–24. Weinberger MH, Luft FC, Bloch R, Henry DP, Pratt JH, Weyman AE, Rankin LI, Murray RH, Willis LR, Grim CE. The blood pressure-raising effects of high dietary sodium intake: Racial differences and the role of potassium.J Am Coll Nutr 1982;1:139–148. Helmer OM, Judson WE. Metabolic studies on hypertensive patients with suppressed plasma renin activity not due to hyperaldosteronism.Circulation 1968;38:965–976. Channick BJ, Adlin EV, Marks AD. Suppressed plasma renin activity in hypertension.Arch Intern Med 1969; 123:131–140. Crane MG, Harris JJ, Johns VJ Jr. Hyporeninemic hypertension.Am J Med 1972;52:457–466. Creditor MC, Loschky VK. Incidence of suppressed renin activity and normokalemic primary aldosteronism in hypertensive Negro patients.Circulation 1968;37:1027–1031. Brunner HR, Sealey JE, Laragh JH. Renin subgroups in essential hypertension.Circ Res 1973;32-33 (Suppl 1):I99-I109. Holland OB, Gomez-Sanchez CE, Fairchild C, Kaplan NM. Role of renin classification for diuretic treatment of black hypertensive patients.Arch Intern Med 1979;139:1365–1370. Kaplan NM, Kem DC, Holland OB, Kramer NJ, Higgins J, Gomez-Sanchez CE. The intravenous furosemide test: A simple way to evaluate renin responsiveness.Ann Intern Med 1976;84:639–645. Levy SB, Lilley JJ, Frigon RP, Stone RA. Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The infleunce of race and sodium intake.J Clin Invest 1977;60:129–138. Lijnen P, M'Buyama-Kabangu JR, Fagard R, Staessen J, Lissens W, Moerman E, Amery A. Racial differences in renin, aldosterone, prostaglandin and kallikrein in normal male subjects.Ann Soc Belge de Med Trop 1985;65:293–301. Voors AW, Berenson GS, Dalferes ER, Webber LS, Shuler SE. Racial differences in blood pressure control.Science 1979;204:1091–1094. Weinberger MH. Antihypertensive therapy and lipids: Evidence, mechanisms and implications.Arch Intern Med 1985;145:1102–1105. Weinberger MH. Antihypertensive therapy and lipids: Paradoxical influences on cardiovascular disease risk.Am J Med 1986;80(2A):64–70. Seedat YK. Trial of atenolol and chlorathalidone for hypertension in black South Africans.Br Med J 1980;281:1241–1243. Plotnick GD, Fisher ML, Hamilton JH, Hamilton BP. Intrinsic sympathomimetic activity of pindolol: Evidence for interaction with pretreatment sympathetic toneAm J Med 1983;74:625–629. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertension.Am J Cardiol 1983;52:1230–1237. Moser M, Lunn J. Comparative effects of pindolol and hydrochlorothiazide in black hypertensive patients.Angiology 1981;32:561–566. Cubberley RB. Labetalol as monotherapy in hypertensive black, patients.J Clin Hypertens 1985;4:304–314. Nichelson E, Frishman WH, et al. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension.Am J Med 1983;75:68–80. Mroczek WJ, Fotin S, Davidov ME, Finnerty FA Jr. Prazosin in hypertension: A double-blind evaluation with methyldopa and placebo.Curr Ther Res 1974;16:769–777. Batey DM, Nicolich MJ, Lasser VI, Jeffrey SS, Lasser NL. Prazosin versus hydrochlorothiazide as initial antihypertensive therapy in black versus white patients.Am J Med (in press). Veterans Administration Cooperative Study Group on Antihypertensive Agents. Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide.Br J Clin Pharmacol 1982;14:97S-101S. Holland OB, Kuhnert L, Campbell WB, Anderson RJ. Synergistic effect of captopril with hydrochlorothiazide for the treatment of low-renin hypertensive black patients.Hypertension 1983;5:235–239. Freier PA, Wollam GL, Hall WD, Unger DJ, Douglas MB, Bain RP. Blood pressure, plasma volume and catecholamine levels during enalapril therapy in blacks with hypertension.Clin Pharmacol Ther 1984;36:731–737. Weinberger MH. Blood pressure and metabolic responses to hydrochlorothiazide, captopril and the combination in black and white mild-to-moderate hypertensive patients.J Cardiovasc Pharmacol 1985;7:S52-S55. Wilkins LH, Dustan HP, Walker JF, Oparil S. Enalapril in low-renin hypertension.Clin Pharmacol Ther 1983;34:297–302. Luft FC, Anoroff GR, Sloan RS, Fineberg NS, Weinberger MH. Calcium channel blockade with nitrendipine.Hypertension 1985;7:438–442. Cubeddu LX, Aranda J, Singh B, et al. A comparison of verapamil and propranolol for the initial treatment of hypertension: Racial differences in response.JAMA 1986;256: 2214–2221. Frishman WH, Zawada ET, Smith LK, et al. Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension.Am J Cardiol 1987;59:615–623. Leary WP, Asmal AC. Treatment of hypertension with verapamil.Curr Ther Res 1979;25:747–752. M'Buyamba-Kabangu JR, Fagard R, Lijnen P, et al. Calcium entry blockade or beta blockade in long-term management of hypertension in blacks.Clin Pharmacol Ther 1987;41:45–54. Moser M, Lunn J, Materson B. Copmparative effects of diltiazem and hydrochlorothiazide in blacks with systemic hypertension.Am J Cardiol 1985;56:1014–1044. Chobanian AV. Antihypertensive therapy in evolution.N Engl J Med 1986;314:1701–1702. Poulter N, Thompson AV, Sever PS. Do diuretics enhance the hypotensive effect of nifedipine? A double-blind cross-over trial in hypertensive patients.J Hypertens 1986;4:792–793. Schoenberger JA, Glasser SP, Ram CVS, et al. Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild-to-moderate essential hypertension.J Cardiovasc Pharmacol 1984;6(Suppl 7): S1105-S1108. Magagna A, Abdel-Haq B, Pedrinelli R, Salvetti A. Does chlorthalidone increase the hypotensive effect of nifedipine?J Hypertens 1984;4(Suppl 5):S519-S521. Hallin L, Andrien L, Hansson L. Controlled trial of nifedipine and bendroflumethiazide in hypertension.J Cardiovasc Pharmacol 1983;5:1083–1085. Latini R, Pieandrei G, Achilli L, Lombi V, D'Amico F. Hypotensive efficacy of verapamil alone and in combination with a diuretic in the treatment of essential hypertension in geriatric patients.G Ital Cardiol 1987;17:144–148. Massie BM, MacCarthy EP, Ramanathan KB, et al. Diltiazem and propranolol in mild-to-moderate essential hypertension as monotherapy or with hydrochlorothiazide.Ann Intern Med 1987;107:150–157. Nicholson JP, Resnick IM, Laragh JH. Hydrochlorothiazide is not additive to verapamil in treating essential hypertension.Arch Intern Med 1989;149:125–128. White WB, Viadero JJ, Lane TJ, Podesla S. Effects of combination therapy with captopril and nifedipine in severe or resistant hypertension.Clin Pharamacol Ther 1986;39:43–48.